kynuramine has been researched along with Psychotic Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergh, JJ; Petzer, JP; Strydom, B | 1 |
| Del Vecchio, M; Famiglietti, LA; Kemali, D; Zizolfi, S | 1 |
2 other study(ies) available for kynuramine and Psychotic Disorders
| Article | Year |
|---|---|
8-Aryl- and alkyloxycaffeine analogues as inhibitors of monoamine oxidase.
Topics: Alkylation; Animals; Binding Sites; Caffeine; Halogens; Humans; Inhibitory Concentration 50; Kinetics; Kynuramine; Mice; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Protein Binding; Psychotic Disorders; Psychotropic Drugs; Recombinant Proteins; Structure-Activity Relationship | 2011 |
Platelet monoamine oxidase and serum dopamine-beta-hydroxylase activities in psychotic patients.
Topics: Adolescent; Adult; Blood Platelets; Dopamine beta-Hydroxylase; Female; Humans; Kynuramine; Male; Middle Aged; Monoamine Oxidase; Psychotic Disorders | 1979 |